+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Low Back Pain - Pipeline Review, H2 2018

  • ID: 4655913
  • Drug Pipelines
  • 113 pages
  • Global Markets Direct
1 of 4

FEATURED COMPANIES

  • Adynxx Inc
  • Array BioPharma Inc
  • Camurus AB
  • Egalet Corp
  • Inspyr Therapeutics Inc
  • Mesoblast Ltd
  • MORE
Low Back Pain - Pipeline Review, H2 2018

Summary

This disease pipeline guide Low Back Pain - Pipeline Review, H2 2018, provides an overview of the Low Back Pain (Central Nervous System) pipeline landscape.

Low back pain can happen anywhere below the ribs and above the legs. Causes of low back pain include overuse, strain, or injury, aging, arthritis, illness and cancer involving the spine. Symptoms include tingling or burning sensation, a dull achy feeling, or sharp pain and weakness in legs or feet. Treatment includes pain medications such NSAIDs (non-steroidal anti-inflammatory drugs) or opioids and muscle relaxants.

Report Highlights

This latest pipeline guide Low Back Pain - Pipeline Review, H2 2018, provides comprehensive information on the therapeutics under development for Low Back Pain (Central Nervous System), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Low Back Pain (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Low Back Pain and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, Preclinical and Discovery stages are 1, 6, 12, 3, 4 and 1 respectively.

Low Back Pain (Central Nervous System) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope
  • The pipeline guide provides a snapshot of the global therapeutic landscape of Low Back Pain (Central Nervous System).
  • The pipeline guide reviews pipeline therapeutics for Low Back Pain (Central Nervous System) by companies and universities/research institutes based on information derived from company and industry-specific sources.
  • The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
  • The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
  • The pipeline guide reviews key companies involved in Low Back Pain (Central Nervous System) therapeutics and enlists all their major and minor projects.
  • The pipeline guide evaluates Low Back Pain (Central Nervous System) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
  • The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
  • The pipeline guide reviews latest news related to pipeline therapeutics for Low Back Pain (Central Nervous System)
Reasons to buy
  • Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
  • Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Find and recognize significant and varied types of therapeutics under development for Low Back Pain (Central Nervous System).
  • Classify potential new clients or partners in the target demographic.
  • Develop tactical initiatives by understanding the focus areas of leading companies.
  • Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
  • Formulate corrective measures for pipeline projects by understanding Low Back Pain (Central Nervous System) pipeline depth and focus of Indication therapeutics.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
  • Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Adynxx Inc
  • Array BioPharma Inc
  • Camurus AB
  • Egalet Corp
  • Inspyr Therapeutics Inc
  • Mesoblast Ltd
  • MORE
Introduction

Low Back Pain - Overview

Low Back Pain - Therapeutics Development

Low Back Pain - Therapeutics Assessment

Low Back Pain - Companies Involved in Therapeutics Development

Low Back Pain - Drug Profiles

Low Back Pain - Dormant Projects

Low Back Pain - Discontinued Products

Low Back Pain - Product Development Milestones

Appendix

List of Tables

Number of Products under Development for Low Back Pain, H2 2018

Number of Products under Development by Companies, H2 2018

Number of Products under Development by Companies, H2 2018 (Contd..1), H2 2018

Products under Development by Companies, H2 2018

Products under Development by Companies, H2 2018 (Contd..1), H2 2018

Number of Products by Stage and Target, H2 2018

Number of Products by Stage and Mechanism of Action, H2 2018

Number of Products by Stage and Route of Administration, H2 2018

Number of Products by Stage and Molecule Type, H2 2018

Low Back Pain - Pipeline by Ache Laboratorios Farmaceuticos SA, H2 2018

Low Back Pain - Pipeline by Adynxx Inc, H2 2018

Low Back Pain - Pipeline by AnGes Inc, H2 2018

Low Back Pain - Pipeline by Array BioPharma Inc, H2 2018

Low Back Pain - Pipeline by Axsome Therapeutics Inc, H2 2018

Low Back Pain - Pipeline by Camurus AB, H2 2018

Low Back Pain - Pipeline by Daewon Pharm Co Ltd, H2 2018

Low Back Pain - Pipeline by Egalet Corp, H2 2018

Low Back Pain - Pipeline by Frontier Biotechnologies Inc, H2 2018

Low Back Pain - Pipeline by Gador SA, H2 2018

Low Back Pain - Pipeline by Hisamitsu Pharmaceutical Co Inc, H2 2018

Low Back Pain - Pipeline by Immune Pharmaceuticals Inc, H2 2018

Low Back Pain - Pipeline by Inspyr Therapeutics Inc, H2 2018

Low Back Pain - Pipeline by MD Biosciences GmbH, H2 2018

Low Back Pain - Pipeline by Mesoblast Ltd, H2 2018

Low Back Pain - Pipeline by Nektar Therapeutics, H2 2018

Low Back Pain - Pipeline by Pacira Pharmaceuticals Inc, H2 2018

Low Back Pain - Pipeline by Pfizer Inc, H2 2018

Low Back Pain - Pipeline by Regeneron Pharmaceuticals Inc, H2 2018

Low Back Pain - Pipeline by Stayble Therapeutics AB, H2 2018

Low Back Pain - Pipeline by Therapix Biosciences Ltd, H2 2018

Low Back Pain - Pipeline by WEX Pharmaceuticals Inc, H2 2018

Low Back Pain - Dormant Projects, H2 2018

Low Back Pain - Dormant Projects, H2 2018 (Contd..1), H2 2018

Low Back Pain - Discontinued Products, H2 2018

List of Figures

Number of Products under Development for Low Back Pain, H2 2018

Number of Products under Development by Companies, H2 2018

Number of Products by Top 10 Targets, H2 2018

Number of Products by Stage and Top 10 Targets, H2 2018

Number of Products by Top 10 Mechanism of Actions, H2 2018

Number of Products by Stage and Top 10 Mechanism of Actions, H2 2018

Number of Products by Top 10 Routes of Administration, H2 2018

Number of Products by Stage and Top 10 Routes of Administration, H2 2018

Number of Products by Molecule Types, H2 2018

Number of Products by Stage and Molecule Types, H2
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Ache Laboratorios Farmaceuticos SA
  • Adynxx Inc
  • AnGes Inc
  • Array BioPharma Inc
  • Axsome Therapeutics Inc
  • Camurus AB
  • Daewon Pharm Co Ltd
  • Egalet Corp
  • Frontier Biotechnologies Inc
  • Gador SA
  • Hisamitsu Pharmaceutical Co Inc
  • Immune Pharmaceuticals Inc
  • Inspyr Therapeutics Inc
  • MD Biosciences GmbH
  • Mesoblast Ltd
  • Nektar Therapeutics
  • Pacira Pharmaceuticals Inc
  • Pfizer Inc
  • Regeneron Pharmaceuticals Inc
  • Stayble Therapeutics AB
  • Therapix Biosciences Ltd
  • WEX Pharmaceuticals Inc
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Order Online - visit: https://www.researchandmarkets.com/reports/4655913
Adroll
adroll